Zions Bancorporation’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$6.5M Buy
24,929
+8,583
+53% +$2.55M 0.41% 45
2024
Q3
$5.27M Sell
16,346
-6,481
-28% -$2.12M 0.38% 52
2024
Q2
$7.13M Buy
22,827
+720
+3% +$212K 0.57% 28
2024
Q1
$6.29M Sell
22,107
-1,119
-5% -$327K 0.46% 34
2023
Q4
$6.69M Sell
23,226
-9,563
-29% -$2.61M 0.46% 33
2023
Q3
$8.81M Buy
32,789
+3,651
+13% +$911K 0.77% 14
2023
Q2
$6.47M Buy
29,138
+11,442
+65% +$2.65M 0.55% 25
2023
Q1
$4.28M Buy
17,696
+7,669
+76% +$1.88M 0.37% 46
2022
Q4
$2.63M Sell
10,027
-10,164
-50% -$2.72M 0.21% 79
2022
Q3
$4.55M Buy
20,191
+5,291
+36% +$1.28M 0.48% 30
2022
Q2
$3.63M Buy
14,900
+1,711
+13% +$419K 0.36% 48
2022
Q1
$3.19M Buy
13,189
+2,847
+28% +$654K 0.29% 46
2021
Q4
$2.33M Buy
10,342
+2,535
+32% +$535K 0.21% 56
2021
Q3
$1.66M Sell
7,807
-417
-5% -$96K 0.17% 74
2021
Q2
$2M Buy
8,224
+334
+4% +$82.2K 0.2% 56
2021
Q1
$1.96M Buy
7,890
+686
+10% +$164K 0.22% 56
2020
Q4
$1.66M Sell
7,204
-7
-0.1% -$1.61K 0.21% 49
2020
Q3
$1.83M Buy
7,211
+374
+5% +$92.7K 0.26% 47
2020
Q2
$1.61M Buy
6,837
+554
+9% +$126K 0.23% 50
2020
Q1
$1.27M Buy
6,283
+457
+8% +$99.8K 0.22% 48
2019
Q4
$1.4M Buy
5,826
+2,586
+80% +$570K 0.2% 46
2019
Q3
$627K Buy
+3,240
New +$622K 0.09% 95
2018
Q4
Sell
-4,504
Closed -$933K 493
2018
Q3
$933K Buy
+4,504
New +$888K 0.22% 56
2017
Q4
Sell
-11,270
Closed -$2.1M 613
2017
Q3
$2.1M Buy
11,270
+1,160
+11% +$206K 0.3% 46
2017
Q2
$1.74M Buy
10,110
+9,948
+6,141% +$1.62M 0.3% 46
2017
Q1
$26K Sell
162
-233
-59% -$38.7K ﹤0.01% 253
2016
Q4
$57K Sell
395
-51
-11% -$7.68K 0.01% 218
2016
Q3
$73K Buy
446
+75
+20% +$12.7K 0.01% 194
2016
Q2
$59K Sell
371
-51
-12% -$7.93K 0.01% 200
2016
Q1
$68K Sell
422
-38
-8% -$5.65K 0.01% 201
2015
Q4
$67K Buy
460
+64
+16% +$10.1K 0.01% 181
2015
Q3
$64K Buy
+396
New +$62.4K 0.01% 183
2015
Q2
Sell
-445
Closed -$71K 277
2015
Q1
$71K Buy
+445
New +$70.1K 0.01% 191

Other funds holding AMGN

Zions Bancorporation's AMGN Position: Q4 2024 in Review

Zions Bancorporation increased its Amgen (AMGN) stake by 53% in Q4 2024, buying an estimated $2.55M and bringing the position to 24,929 shares worth $6.5M. The position accounts for 0.41% of the portfolio, ranked #45.

Zions Bancorporation first reported a position in AMGN in Q1 2015 and has held it in 33 quarters since. The position peaked at $8.81M in Q3 2023. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Zions Bancorporation held 24,929 shares of Amgen worth $6.5M as of Q4 2024.
  • Zions Bancorporation bought 8,583 Amgen shares in Q4 2024, an estimated $2.55M.
  • Amgen made up 0.41% of Zions Bancorporation's portfolio in Q4 2024, its #45 holding.
  • Zions Bancorporation first reported a position in Amgen in Q1 2015 and has held it in 33 quarters since.
  • Zions Bancorporation's Amgen position peaked at $8.81M in Q3 2023.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.